Actionable insights straight to your inbox

Equities logo

Novo Nordisk To Acquire Dicerna Pharmaceuticals for $3.3 Billion

Dicerna Pharmaceuticals (DRNA) is a biopharmaceutical company focused on the discovery and development of innovative treatments for rare inherited diseases involving the liver and for cancers that